ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas (Q61950032)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

main subject

endometrial hyperplasia

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

10

Lars A Akslen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

11

Jone Trovik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

12

Helga B Salvesen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

4

Even Birkeland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Henrica M J Werner

1

object named as

Henrica M J Werner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Anna Berg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Elisabeth Wik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Kanthida Kusonmano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Kjell Petersen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Karl H Kalland

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Anne M Oyan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

19 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

428-434

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23080032%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2012.174

15 February 2020

exact match

0 references

cites work

Endometrial adenocarcinoma in Norway. A study of a total population

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

1 reference

7 January 2021

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

ARID1A mutations in endometriosis-associated ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

The SWI/SNF complex and cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

SWI/SNF nucleosome remodellers and cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Understanding the words of chromatin regulation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Genomic and functional evidence for an ARID1A tumor suppressor role

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Revised FIGO staging for carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Tissue microarrays in clinical oncology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Expression profiling of epithelial plasticity in tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021

Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.174

7 January 2021